Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1904890

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1904890

Sleep Disorder Market Size, Share, and Growth Analysis, By Disorder Type (Insomnia, Sleep Apnea), By Product (Diagnostics, Therapeutics), By End-use, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Sleep Disorder Market size was valued at USD 30.39 Billion in 2024 and is poised to grow from USD 33.46 Billion in 2025 to USD 72.24 Billion by 2033, growing at a CAGR of 10.1% during the forecast period (2026-2033).

The global Sleep Disorder Market focuses on the diagnosis, treatment, and management of various conditions that affect sleep quality and duration. As awareness of sleep's crucial role in overall health increases, the market is experiencing notable growth. Conditions like insomnia, sleep apnea, and restless legs syndrome are at the forefront of this demand, driven by changing lifestyles, heightened stress, and rising sleep-related health issues. Technological advancements are enhancing diagnostic and treatment options, including innovative wearable devices and telemedicine. The aging population, along with the rising rates of obesity and chronic conditions such as diabetes that exacerbate sleep disorders, further accelerates the market expansion. Overall, there is a sustained investment in research and development to provide effective interventions for those facing sleep challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Sleep Disorder market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Sleep Disorder Market Segments Analysis

Global Sleep Disorder Market is segmented by Disorder Type, Product, End-use and region. Based on Disorder Type, the market is segmented into Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy and Circadian Rhythm Disorders. Based on Product, the market is segmented into Diagnostics and Therapeutics. Based on End-use, the market is segmented into Hospitals & Sleep Laboratories and Home Care Settings & Individuals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Sleep Disorder Market

The heightened awareness surrounding the negative health consequences associated with sleep disorders serves as a significant catalyst for the market. As education and information sharing intensify across multiple platforms, more individuals are recognizing the importance of addressing their sleep-related problems. This shift in understanding encourages people to pursue proper diagnosis and treatment options, thereby fostering a growing demand for solutions in the sleep disorder market. The ongoing dialogue about mental and physical well-being further amplifies the urgency for effective interventions, leading to a greater emphasis on managing sleep disorders and improving overall health outcomes in affected populations.

Restraints in the Sleep Disorder Market

The sleep disorder market faces notable restraints due to persistent stigma surrounding these conditions, which often prevents individuals from pursuing necessary professional assistance. Furthermore, in various regions, a lack of awareness regarding the nature and severity of sleep disorders hampers timely diagnosis and appropriate treatment. As a result, many individuals may endure these disorders in silence, missing out on effective interventions that could significantly improve their quality of life. This combination of societal stigma and regional knowledge gaps poses challenges for market growth and the accessibility of care for those affected by sleep-related issues.

Market Trends of the Sleep Disorder Market

The Sleep Disorder market is witnessing a significant trend towards telemedicine and remote monitoring, reflecting a broader shift in healthcare delivery. Patients increasingly prefer the convenience of receiving sleep disorder diagnosis and treatment from home, facilitated by advancements in technology. Virtual sleep clinics and wearable devices for remote monitoring are becoming mainstream, offering real-time data and personalized treatment plans. This evolution not only enhances accessibility for patients but also optimizes clinician efficiency. As the demand for flexible healthcare solutions grows, the integration of digital health tools in sleep disorder management is expected to transform traditional approaches, benefiting both consumers and providers.

Product Code: SQMIG35D2156

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Patent Analysis

Global Sleep Disorder Market Size by Disorder Type & CAGR (2026-2033)

  • Market Overview
  • Insomnia
  • Sleep Apnea
  • Restless Legs Syndrome
  • Narcolepsy
  • Circadian Rhythm Disorders

Global Sleep Disorder Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Diagnostics
  • Therapeutics

Global Sleep Disorder Market Size by End-use & CAGR (2026-2033)

  • Market Overview
  • Hospitals & Sleep Laboratories
  • Home Care Settings & Individuals

Global Sleep Disorder Market Size & CAGR (2026-2033)

  • North America (Disorder Type, Product, End-use)
    • US
    • Canada
  • Europe (Disorder Type, Product, End-use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Disorder Type, Product, End-use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Disorder Type, Product, End-use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Disorder Type, Product, End-use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Merck & Co., Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylan N.V. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takeda Pharmaceutical Company Limited (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jazz Pharmaceuticals plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ResMed Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fisher & Paykel Healthcare Corporation Limited (New Zealand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Natus Medical Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Compumedics Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vyaire Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SomnoMed Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Drive DeVilbiss Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cadwell Industries, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!